Whitehawk Therapeutics, Inc.
WHWK· Nasdaq
Released Aug 12, 2020, before the open
10-Q filed Aug 12, 2020, 43 days after period end · 0001564590-20-039505
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $15.00M | — | $1.33M | — |
| Net Income | -$5.28M | -$5.68M | -$5.99M | -$5.52M |
| EPS Diluted |
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
| $0.23 |
| -$0.14 |
| -$0.22 |
| -$0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.